发明名称 Enolase peptide conjugate vaccines against <i>Staphylococcus aureus</i>
摘要 The present invention relates to peptides of the enolase protein from Staphylococcus aureus as well as nucleic acid and nucleic acid sequence homologs encoding the peptides. The present invention also relates to a composition, particularly a S. aureus vaccine, comprising one or more of the enolase peptides described herein or a fragment, derivative or variant thereof capable of generating an immune response that induces a protective antibody response or opsonophagocytic activity of human neutrophils for S. aureus. The present invention also encompasses methods of treating and/or reducing the likelihood of a Staphylococcus infection by administering a composition of the invention.
申请公布号 US9447403(B2) 申请公布日期 2016.09.20
申请号 US201314045433 申请日期 2013.10.03
申请人 Merck Sharp & Dohme Corp. 发明人 McNeely Tessie B.;Cope Leslie;Smith Sharon;Joshi Amita;Pak Irene;Fridman Arthur
分类号 C07K14/31;A61K39/085;C12N9/88;A61K38/00;A61K39/00 主分类号 C07K14/31
代理机构 代理人 Wu Henry P.;Thampoe Immac J.
主权项 1. An isolated enolase peptide derivative, wherein said derivative comprises an enolase peptide and one or more additional not naturally associated regions or moieties covalently joined to said amino acid sequence, wherein the enolase peptide consists of a sequence of amino acids as set forth in SEQ ID NO:6 or consists essentially of SEQ ID NO:6 and between 1 and 10 additional amino acids, wherein each region or moiety is independently selected from a region or moiety having at least one of the following properties: enhances the immune response, facilitates purification, or facilitates polypeptide stability.
地址 Rahway NJ US